Neuroprotection

Happy New Year from #Neuroprotection! We are excited for what is to come in 2026. May it be a successful one for all of you as well.

Breakthrough for #SAH patients

@wileyinresearch @struglin_scigal @neeliewong @agetliang

New review in #Neuroprotection: 🛡️ Regulatory B cells in the CNS doi.org/10.1002/nep3.7…⁠ IL-10–secreting Bregs suppress #neuroinflammation, promote regulatory T cells & may enhance neuronal survival after injury. Promising neuroprotective targets - but immune balance is key.

Now in #Neuroprotection: Repair Study protocol - a multicenter, triple-blinded RCT of VNS paired with #rehabilitation in chronic ischemic #stroke. Strengthening global evidence for VNS in stroke recovery. onlinelibrary.wiley.com/doi/10.1002/ne…

Celebrating our #WomenInScience of our editorial board and managing editors Shen Li, @struglin_scigal, Heleen van Beusekom, @neeliewong, Yun Wang, Zhe Liu, Siyue Xiao, @ZilleMarietta @wileyinresearch @WileyGlobal

Celebrating all #womeninscience, not only at our Faculty of Life Sciences and all other faculties @univienna, but around the world!! We should celebrate this each and every day of the year. Science needs all of us. Keep it up!

Time is running out to showcase your latest research at #ESOC2026. Large clinical trials, ongoing trials & late breaking abstracts submissions, are still open 🔗Submit your abstract until 12 Feb: ow.ly/Rr7e50XTY7s #StrokeResearch #Neurology #VoiceOfStroke #Stroke

It is the final day of #ISC2026. Ongoing right now is a fantastic session on the #aging immune system and its implications for cerebrovascular disease and brain health

A breakthrough in secondary prevention. Asundexian reduced ischemic stroke risk without increased bleeding. Congratulations to Mike Sharma and @Ash_Shoamanesh and the OCEANIC-STROKE team. Well done 👏 #ISC26

Welcome from AHA leadership, Presidential Address, Feinberg Award Lecture, and major clinical trial updates — an exciting start to the meeting. Led by Lauren H Sansing #ISC26 @StrokeAHA_ASA

Highlight of Day 2 at #ISC2026: Raghu Vemuganti is awarded the Thomas Willis Award for his work on RNAs in #stroke. Congrats Raghu. So well deserved.

Cell therapy for stroke is evolving — from early trials to smarter next-gen strategies. Exciting discussion on how to get it right at #ISC26 Moderated by Drs. Gary K. Steinberg & Cesar V. Borlongan. @StrokeAHA_ASA

#CHOICE-2 #IAT #alteplase following successful #EVT associated with better outcomes! #ISC26 @AHAScience @StrokeAHA_ASA @svinsociety @SVINJournal

Attending a presentation on brain cell-type–specific vulnerabilities following hemorrhage by Marietta Zille (University of Vienna). #ISC26 Focused discussion on differential cellular responses and implications for targeted therapeutic strategies. @StrokeAHA_ASA

Sitting in on a talk about targeting the hemostatic cascade in ICH by Kunjan R Dave. #ISC26 Nice overview of the potential of RMP in ICH therapies. @StrokeAHA_ASA

Listening to a talk on miRNAs in cerebrovascular disease by Tracy D Farr. Interesting perspective on microRNA regulation in cerebrovascular disease #ISC26 @StrokeAHA_ASA

ISC Invited Symposium on molecular mechanisms of brain injury — moderated by Drs. Ami Raval & Raghu Vemuganti.🧠✨ #ISC26 @StrokeAHA_ASA

It is Day 1 of #ISC2026 and we are excited to catch the session featuring our editorial board members @struglin_scigal and @ZilleMarietta in what will be a fantastic session. See you there!

Neuroprotection journal was officially accepted for inclusion in the China Open Access Journal (COAJ) database. This marks yet another significant milestone in the journal's progress toward being indexed in authoritative databases.